YM 161514

Drug Profile

YM 161514

Alternative Names: YM 151; YM 161511

Latest Information Update: 22 Dec 2000

Price : $50

At a glance

  • Originator Yamanouchi
  • Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Angina pectoris; Hypertension

Most Recent Events

  • 22 Dec 2000 No-Development-Reported for Hypertension in European Union (PO)
  • 22 Dec 2000 No-Development-Reported for Angina pectoris in European Union (Unknown route)
  • 22 Dec 2000 No-Development-Reported for Hypertension in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top